5-Iodo-2,3-dihydropyridazin-3-one → (S)-2-(2-(tert-butyldimethylsilyloxy)-1-(4-chloro-3-fluorophenyl)ethyl)-5-iodopyridazin-3(2H)-one

HRID 1774181

Reaktionsgleichung

Reaktionsgleichung von HRID 1774181
CC([O-])(C)C.[K+].[I:7][C:8]1[CH:13]=[N:12][NH:11][C:10](=[O:14])[CH:9]=1.CS(O[C@H:20]([C:30]1[CH:35]=[CH:34][C:33]([Cl:36])=[C:32]([F:37])[CH:31]=1)[CH2:21][O:22][Si:23]([C:26]([CH3:29])([CH3:28])[CH3:27])([CH3:25])[CH3:24])(=O)=O>C1COCC1.[I-].C([N+](CCCC)(CCCC)CCCC)CCC>[Si:23]([O:22][CH2:21][C@@H:20]([N:11]1[C:10](=[O:14])[CH:9]=[C:8]([I:7])[CH:13]=[N:12]1)[C:30]1[CH:35]=[CH:34][C:33]([Cl:36])=[C:32]([F:37])[CH:31]=1)([C:26]([CH3:28])([CH3:29])[CH3:27])([CH3:25])[CH3:24]

Komponenten

6

Edukt 3

HCID 166383305-Iodo-2,3-dihydropyridazin-3-oneHCID 23665647Potassium tert-butoxideHCID 71726881Benzenemethanol, 4-chloro-alpha-((((1,1-dimethylethyl)dimethylsilyl)oxy)methyl)-3-fluoro-, 1-methanesulfonate, (alphaR)-

Produkt 1

HCID 86696678(S)-2-(2-(tert-butyldimethylsilyloxy)-1-(4-chloro-3-fluorophenyl)ethyl)-5-iodopyridazin-3(2H)-oneAusbeute 63 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 67553Tetrabutylammonium IodideKatalysatorHCID 8028TetrahydrofuranLösungsmittel3×

Versuchsvorschrift

1.0M KOt-Bu (2.64 mL, 2.64 mmol) in THF and tetrabutylammonium iodide (0.0749 g, 0.203 mmol) were added to a solution of 5-iodopyridazin-3(2H)-one (0.45 g, 2.03 mmol) in THF (10 mL). The mixture was stirred at room temperature for 10 minutes before (R)-2-(tert-butyldimethylsilyloxy)-1-(4-chloro-3-fluorophenyl)ethyl methanesulfonate (1.16 g, 3.04 mmol) was added as a solution in THF (10 mL) The reaction was heated to reflux for 90 hours, then cooled to room temperature and concentrated. The residue was taken up in ethyl acetate and washed with water (2×). The organics were dried, filtered and concentrated. The crude product was purified via column chromatography, eluting with hexanes/ethyl acetate (25:1) to give (S)-2-(2-(tert-butyldimethylsilyloxy)-1-(4-chloro-3-fluorophenyl)ethyl)-5-iodopyridazin-3(2H)-one (0.65 g, 63%). 1H NMR (400 MHz, CDCl3) δ 7.98 (d, J=2.0 Hz, 1H), 7.45 (d, J=2.2 Hz, 1H), 7.35 (m, 1H), 7.23 (m, 1H), 7.16 (m, 1H), 6.09 (m, 1H), 4.34 (m, 1H), 4.01 (m, 1H), 0.81 (s, 9H), 0.01 (s, 3H), −0.01 (s, 3H).

Aufarbeitung

  1. temperaturewas heated
  2. temperatureto reflux for 90 hours
  3. concentrationconcentrated
  4. washwashed with water (2×)
  5. customThe organics were dried
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customThe crude product was purified via column chromatography
  9. washeluting with hexanes/ethyl acetate (25:1)

Quellen und Nachweise

ORD-Eintrag
ord-3bf47e80da8f40beb3072258bc5980c1
Quelldatensatz
uspto-grants-2016_02
Patentnummer
US09259470B2

Verknüpfte Notizen

Wird geladen…